ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors

@article{Falconi2011ENETSCG,
  title={ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors},
  author={Massimo Falconi and Detlef Klaus Bartsch and Barbro K. Eriksson and G{\"u}nter Kl{\"o}ppel and Jos{\'e} Manuel Lopes and Juan Manuel O'Connor and Ramon Salazar and Babs G. Taal and Marie-Pierre Vullierme and Dermot O'Toole},
  journal={Neuroendocrinology},
  year={2011},
  volume={95},
  pages={120 - 134}
}
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System : Well-Differentiated Pancreatic Non-Functioning Tumors 

Figures and Tables from this paper

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
TLDR
The ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatics with Functional and non-functional tumours is published.
Outcome of surgery for pancreatic neuroendocrine neoplasms
TLDR
The incidence of pancreatic neuroendocrine neoplasms (pNEN) is increasing and predictors of overall survival and the indication for surgery are evaluated.
Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas
TLDR
This chapter focuses on the debate between surgery and chemotherapy for metastatic PNET, and summarizes the evidence for both strategies including which treatment is appropriate in each clinical setting.
Management and outcomes of patients for non‐functioning pancreatic neuroendocrine tumours: a multi‐institutional analysis
To analysed the short‐ and long‐term outcomes of patients who underwent surgical resection for non‐functioning pancreatic neuroendocrine tumours (NF‐PNETs) to gain insights into treatment approaches
Surgical Management of Pancreatic Neuroendocrine Tumors.
Pancreatic neuroendocrine tumors
TLDR
Current understanding of pancreatic NETs in terms of their incidence, pathology, and management is put into perspective.
Systematic review of active surveillance versus surgical management of asymptomatic small non‐functioning pancreatic neuroendocrine neoplasms
TLDR
The aim of this study was systematically to evaluate the literature on active surveillance and to compare this with surgical management for asymptomatic sporadic small NF‐PNENs.
Guideline for the Management of Pancreatic Neuroendocrine Tumor
TLDR
Pancreatic neuroendocrine neoplasms (PNENs) have been steadily increasing in terms of incidence and prevalence over the last two decades, while in others cases can manifest at advanced stages when symptom control is the only rationale for surgical treatment.
Neuroendocrine Pancreatic Tumors
TLDR
PNETs are a complex and heterogeneous group of neoplasms which can present as single or multiple lesions, sporadic or associated to a genetic syndrome.
...
...

References

SHOWING 1-10 OF 180 REFERENCES
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Pancreatic neuroendocrine tumors
TLDR
The authors investigated the survival advantage of pancreatic resection using a national database and found that surgical resection is generally recommended for patients with localized pancreatic neuroendocrine tumors.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Biomarkers have been the mainstay in the diagnosis and follow-up of patients with neuroendocrine tumors (NETs) over the last few decades. In the beginning, secretory products from a variety of subtype
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations
TLDR
The ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors : Radiological Examinations show clear trends in acceptable levels of care for these patients and provide a roadmap for future generations to follow.
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a rare but challenging group of malignant neoplasms and occur at virtually any site of the GEP system. In 2006, a new
Clinical outcome and long‐term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas
The aim was to assess the clinical relevance of the World Health Organization and tumour node metastasis (TNM) classifications in patients with pancreatic neuroendocrine tumours (pNETs).
MRI of pancreatic neuroendocrine tumours.
TLDR
The spectrum of MRI appearances of pancreatic neuroendocrine tumours is reviewed to suggest that MRI may have an important role in their localization.
Pancreatic insufficiency after different resections for benign tumours
TLDR
The aim of this study was to compare postoperative and long‐term results after different pancreatic resections for benign disease.
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors
The objective of this study was to determine the prognostic variables that influence response and survival in patients with metastatic neuroendocrine tumors who are treated with hepatic arterial
...
...